Literature DB >> 29205980

Retinopathy of prematurity - from recognition of risk factors to treatment recommendations.

Reija Fagerholm, Eija Vesti.   

Abstract

Retinopathy of prematurity is a proliferative retinal disorder diagnosed exclusively in prematurely born infants. In retinopathy of prematurity, growth of the retinal vasculature is disturbed, leading to hypoxia-induced pathological changes typical of retinopathy of prematurity, in the worst case resulting in retinal detachment. The most typical risk factors predisposing to the disease include hyperoxemia, low levels of insulin-like growth factor 1 (IGF-I), and low birth weight in relation to weeks of pregnancy. Laser therapy of peripheral retina is the currently established form of treatment. Screening is applied in order to recognize the pathological changes in retinopathy of prematurity early enough.

Entities:  

Mesh:

Year:  2017        PMID: 29205980

Source DB:  PubMed          Journal:  Duodecim        ISSN: 0012-7183


  4 in total

1.  Evaluation of the prematurity retinopathy and other eye changes in the newborn.

Authors:  Thiago Gonçalves Dos Santos Martins; Leticia de Araújo Franco Andreghetto; Rafael Maciel Brito; Luciane Benitez Provenzano; Susan Fowler
Journal:  Einstein (Sao Paulo)       Date:  2022-05-06

2.  Incidence and Risk Factors for Retinopathy of Prematurity in Tabuk City, KSA.

Authors:  Hani B AlBalawi; Nada S AlBalawi; Nada A AlSuhaimi; Amani A AlBalawi; Amani S AlAtawi; Hyder O Mirghani; Hassan A Al-Dhibi; Saad H AlEnezi
Journal:  Middle East Afr J Ophthalmol       Date:  2020-07-20

3.  Effects of LY294002 on the function of retinal endothelial cell in vitro.

Authors:  Yu Di; Xiao-Long Chen
Journal:  Int J Ophthalmol       Date:  2018-09-18       Impact factor: 1.645

4.  β‑elemene inhibits oxygen‑induced retinal neovascularization via promoting miR‑27a and reducing VEGF expression.

Authors:  Weilai Zhang; Lei Chen; Jin Geng; Limin Liu; Li Xu
Journal:  Mol Med Rep       Date:  2019-01-15       Impact factor: 3.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.